Interpretation of the updates of the NCCN esophageal and esophagogastric junction cancers clinical practice guidelines in oncology (version 3. 2023)
- VernacularTitle:《NCCN食管和食管胃结合部癌临床实践指南（2023年第3版）》更新解读
- Author:
Yi, WANG
1
;
Chen ZHENG
1
;
Qihui LI
1
;
Jun WANG
1
Author Information
1. Department of Radiotherapy, The Fourth Hospital of Hebei Medical University, Shijiazhuang, 050000, P. R. China
- Publication Type:Journal Article
- Keywords:
Esophageal cancer;
esophagogastric junction cancer;
NCCN guideline;
guideline interpretation
- From:
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
2024;31(01):11-16
- CountryChina
- Language:Chinese
-
Abstract:
Esophageal cancer is the seventh most common cancer worldwide. On August 29, 2023, National Comprehensive Cancer Network (NCCN) released the NCCN esophageal and esophagogastric junction cancers clinical practice guidelines in oncology (version 3. 2023). This article aims to highlight the key updates in treatment and follow-up recommendations between the version 3 and the version 2 in 2023, providing the latest guidance for the management of esophageal cancer in our country.
